Comparison of the Oral Steroids, Macrolides and Combination Therapy in Nasal Polyposis Patients

Fatih Tetik, Arzu Yasemin Korkut, Kerem Sami Kaya, Irmak Ucak, Irfan Celebi, Berna Uslu Coskun, Fatih Tetik, Arzu Yasemin Korkut, Kerem Sami Kaya, Irmak Ucak, Irfan Celebi, Berna Uslu Coskun

Abstract

Objectives: In this study, our aim was to compare oral steroid therapy with macrolide therapy and with oral steroid + macrolide (combine) therapy in patients with nasal polyposis (NP).

Methods: All patients were treated with nasal steroid therapy for eight weeks and divided randomly into three groups as follows: Oral steroid group, oral macrolide group and combine group. All patients underwent endoscopic staging, radiological grading, odour testing and completed the sino-nasal outcome test-22 (SNOT-22) questionnaire before and after treatment.

Results: Significant improvement was observed in all parameters after treatment in all three groups. All parameters were significantly better in the combined group than in the macrolide group. Comparison of the oral steroid group and macrolide group revealed significantly better radiological grading and odour test changes for the oral steroid group, but no statistically significant differences existed according to endoscopic staging and SNOT-22. The post-treatment SNOT-22 score was significantly better in the combined group than in the steroid group. A comparison of the combined and steroid groups showed better results for the combined group for all parameters, but the differences were not significant.

Conclusion: All treatment protocols were effective and the successful use of macrolide indicates its potential as an alternative in patients with contraindications to oral steroid treatment. The combined treatment may demonstrate significantly better results than steroid treatment alone if larger studies with more patients are performed.

Keywords: Chronic rhinosinusitis; macrolide; nasal polyposis; nasal steroid; oral steroid.

Conflict of interest statement

Conflict of Interest: None declared.

Copyright: © 2020 by The Medical Bulletin of Sisli Etfal Hospital.

References

    1. Andrews AE, Bryson JM, Rowe-Jones JM. Site of origin of nasal polyps:relevance to pathogenesis and management. Rhinology. 2005;43:180–4.
    1. Sabirov A, Hamilton RG, Jacobs JB, Hillman DE, Lebowitz RA, Watts JD. Role of local immunoglobulin E specific for Alternaria alternata in the pathogenesis of nasal polyposis. Laryngoscope. 2008;118:4–9.
    1. Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. 2008;4:507–12.
    1. Sarıoglu T, Bayar N, Kanbur B, Gündüz M. Treatment methods in recurrent nasal polyps. Drug and Treatment Journal. 1993;6:12–4.
    1. Erbek SS, Erbek S, Budakoğlu I, Cakmak O. The relationship between smoking and nasal polyposis. Kulak Burun Bogaz Ihtis Derg. 2008;18:216–20.
    1. Stammberger H. Rhinoscopic surgery. In: Settipane GA, Lund VJ, Bernstein JM, Tos M, editors. Nasal polyps:epidemiology, pathogenesis and treatment. Rhode Island: Ocean Side Pub; 1997. pp. 7–15.
    1. Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P. Pharmacological management of nasal polyposis. Drugs. 2005;65:1537–52.
    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012:European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50:1–12.
    1. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31:183–4.
    1. HancıD Altun H, Şahin E, Altıntoprak N, Cingi C. Turkish translation, cross-cultural adaptation and validation of the Sino Nasal Outcome Test (SNOT)-22. ENT Updates. 2015;5:51–7.
    1. Kobayashi M, Reiter ER, DiNardo LJ, Costanzo RM. A new clinical olfactory function test:cross-cultural influence. Arch Otolaryngol Head Neck Surg. 2007;133:331–6.
    1. Veyseller B, Ozucer B, Karaaltin AB, Yildirim Y, Degirmenci N, Aksoy F, et al. Connecticut (CCCRC) Olfactory Test:Normative Values in 426 Healthy Volunteers. Indian J Otolaryngol Head Neck Surg. 2014;66:31–4.
    1. Schalek P, Petrás P, Klement V, Hahn A. Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains. Eur Arch Otorhinolaryngol. 2009;266:1909–13.
    1. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14:143–8.
    1. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 1997;182:115–24.
    1. Varvyanskaya A, Lopatin A. Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2014;4:533–41.
    1. Perić A, Baletić N, Milojević M, Sotirović J, Živić L, Perić AV, et al. Effects of Preoperative Clarithromycin Administration in Patients with Nasal Polyposis. West Indian Med J. 2014;63:721–7.
    1. Luo Q, Deng J, Xu R, Zuo K, Li H, Shi J. Clinical effect of clarithromycin therapy in patients with chronic rhinosinusitis [Article in Chinese] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49:103–8.
    1. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline:two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069–76.
    1. Kuran G, Kocatürk S, Kurukahvecioğlu S, Erkam U. The efficacy of combined medical treatment (antihistaminics, steroids, and macrolide antibiotics) in patients with nasal polyposis:preliminary results. Kulak Burun Bogaz Ihtis Derg. 2002;9:352–7.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi